Feedback

Browsing by I

Use an asterisk (*) for partial word searches (e.g. pemph*)

114 results found.

1.
Ordering Recommendation:   If pursuing antibody testing to determine autoimmune diabetes mellitus, perform at least 2 antibody tests. Other antibody tests include Glutamic Acid Decarboxylase Antibody (2001771), Insulin Antibody (0099228), Islet Cell Cytoplasmic Antibody, IgG (0050138), and Zinc Transporter 8 Antibody (2006196).
Most useful to establish autoimmumne etiology in previously diagnosed type 1 DM.
Do not use to differentiate type 1 versus type 2 DM, for most cases.
2.
Ordering Recommendation:   Optimize drug therapy and monitor patient adherence.
3.
Ordering Recommendation:   Prognostic testing for individual with glioma. Secondary test for prognostication of CN-AML.
4.
Ordering Recommendation:   Use when morphology indicates tumor may be a glioma. May use to differentiate tumor from reactive gliosis.
5.
Ordering Recommendation:   Refer to ARUP Immunohistochemistry Stain Offerings brochure at www.aruplab.com/ap/resources.
6.
7.
Ordering Recommendation:   Research interest only. For suspected growth hormone disorders, insulin-like growth factor 1 (IGF-1) (0070125) and growth hormone testing (Insulin-Like Growth Factor 1; Growth Hormone) (0070080) is recommended.
8.
Ordering Recommendation:   Not a first-line test in the evaluation of growth disorders. Aids in workup of suspected anterior hypopituitarism.
9.
Ordering Recommendation:   Aids in diagnosis of growth hormone excess or deficiency disorders.
10.
Ordering Recommendation:   Most sensitive method to detect IGH-BCL2 fusion in formalin-fixed, paraffin-embedded (FFPE) tissue specimens.
11.
Ordering Recommendation:   Aids in diagnosis of mantle cell lymphoma if cyclin testing is noninformative.
12.
Ordering Recommendation:   Aids in diagnosis of mantle cell lymphoma if cyclin testing is noninformative.
13.
Ordering Recommendation:   Facilitates diagnosis of Burkitt lymphoma (BL) and B-cell lymphoma with features intermediate between BL and diffuse large B-cell lymphoma (DLBCL).
14.
Ordering Recommendation:   Determine risk group in newly diagnosed CLL.
15.
Ordering Recommendation:   Optimize drug therapy and monitor patient adherence.
16.
17.
Ordering Recommendation:   Use in the initial evaluation of individuals with serum monoclonal protein present and negative IgG, IgA, and IgM immunofixation studies.
18.
Ordering Recommendation:   Qualitative test confirms the presence of a monoclonal protein and classifies its heavy- and light- chain type. Aids in the detection and management of multiple myeloma and related disorders.
19.
Ordering Recommendation:   Determine whether to use IgA or IgG tTG and DGP assays.
20.
Ordering Recommendation:   Refer to ARUP Immunohistochemistry Stain Offerings brochure at www.aruplab.com/ap/resources.
21.
22.
23.
24.
Ordering Recommendation:   Refer to ARUP Immunohistochemistry Stain Offerings brochure at www.aruplab.com/ap/resources.
25.
26.
27.
28.
Ordering Recommendation:   Refer to ARUP Immunohistochemistry Stain Offerings brochure at www.aruplab.com/ap/resources.
29.
30.
31.
32.
33.
Ordering Recommendation:   Do not order for total IgG measurements. Secondary test in suspected immunoglobulin deficiency. Do not order before IgG, IgA, and IgM measurements are performed.
34.
35.
Ordering Recommendation:   Preferred test is Oligoclonal Band Profile (0080440). Index test aids in the workup of suspected multiple sclerosis.
36.
37.
Ordering Recommendation:   Refer to ARUP Immunohistochemistry Stain Offerings brochure at www.aruplab.com/ap/resources.
38.
39.
Ordering Recommendation:   Refer to ARUP Immunohistochemistry Stain Offerings brochure at www.aruplab.com/ap/resources.
40.
41.
Ordering Recommendation:   Initial test in the workup of immunoglobulin disorders. In adults and older children with suspected hypogammaglobulinemia, order in conjunction with serum protein electrophoresis and immunofixation.
42.
43.
44.
Ordering Recommendation:   Useful as an indicator of small intestine dysbiosis; not recommended for routine use in the diagnosis of gastrointestinal pathological conditions.
45.
Ordering Recommendation:   Refer to Additional Technical Information document.
46.
Ordering Recommendation:   May be a useful tool for distinguishing ulcerative colitis (UC) from Crohn disease (CD) in patients with suspected inflammatory bowel disease.
47.
Ordering Recommendation:   Evaluate response failure to infliximab therapy. Determine and adjust dosage or identify the need for change to another anti-TNF-a inhibitor.
48.
49.
Ordering Recommendation:   Do not use to diagnose acute influenza infections. Serological testing for influenza should be used for research and public health investigations only.
50.
Ordering Recommendation:   Do not use to diagnose acute influenza infections. Serological testing for influenza should be used for research and public health investigations only.
51.
Ordering Recommendation:   Do not use to diagnose acute influenza infections. Serological testing for influenza should be used for research and public health investigations only.
52.
Ordering Recommendation:   Do not use to diagnose acute influenza infections. Serological testing for influenza should be used for research and public health investigations only.
53.
54.
Ordering Recommendation:   Follow-up test for patients with documented influenza A. Not a first-line test for the detection of suspected influenza in most clinical situations. Detects and subtypes the 2 predominant strains of circulating influenza A (H1N1 and H3N2).
55.
Ordering Recommendation:   Do not use to diagnose acute influenza infections. Serological testing for influenza should be used for research and public health investigations only.
56.
Ordering Recommendation:   Do not use to diagnose acute influenza infections. Serological testing for influenza should be used for research and public health investigations only.
57.
Ordering Recommendation:   Do not use to diagnose acute influenza infections. Serological testing for influenza should be used for research and public health investigations only.
58.
Ordering Recommendation:   Not recommended for inpatients or immunocompromised individuals. Acceptable test for the detection of influenza in outpatients.
59.
Ordering Recommendation:   Acceptable test to detect influenza during influenza season.
60.
Ordering Recommendation:   Not a preferred stand-alone test.
61.
Ordering Recommendation:   Molecular (DNA) test to confirm a diagnosis of inherited insulin resistance syndrome. To diagnose or rule out inherited insulin resistance syndrome, refer to Insulin, Fasting (0070063), or Fasting Glucose, Plasma or Serum (0020024),
62.
63.
Ordering Recommendation:   May be used for infertility evaluation. Use to differentiate ovarian tumor with normal CA-125 from stromal or mucinous epithelial tumor. May be used for monitoring recurrence of stromal ovarian tumors.
64.
Ordering Recommendation:   Refer to ARUP Immunohistochemistry Stain Offerings brochure at www.aruplab.com/ap/resources.
65.
Ordering Recommendation:   Initial screen for inhibitor in plasma.
66.
Ordering Recommendation:   Initial screen for inhibitor in plasma.
67.
Ordering Recommendation:   Refer to ARUP Immunohistochemistry Stain Offerings brochure at www.aruplab.com/ap/resources.
68.
Ordering Recommendation:   Predict response to peginterferon (PEG-IFNa) and ribavirin (RBV) therapy for chronic HCV-1 infection. Aid in dose planning for chronic HCV-1 infection. Predict risk of RBV treatment-related anemia.
69.
Ordering Recommendation:   Preferred test for evaluating acute and chronic exposure to organophosphate pesticides.
70.
Ordering Recommendation:   Use to determine presence of antibodies to exogenous insulin analogues. Testing not recommended for patients receiving insulin >2 weeks, as insulin antibody formation may occur.
If pursuing antibody testing to determine autoimmune diabetes mellitus, perform at least 2 antibody tests. Other antibody tests include Glutamic Acid Decarboxylase Antibody (2001771), IA-2 Antibody (0050202), Islet Cell Cytoplasmic Antibody, IgG (0050138), and Zinc Transporter 8 Antibody (2006196).
Do not use to differentiate type 1 versus type 2 DM, for most cases.
71.
72.
73.
74.
75.
Ordering Recommendation:   Aids in the detection of insulinoma. Do not use to diagnose diabetes mellitus.
76.
Ordering Recommendation:   Not recommended to diagnose diabetes mellitus.
77.
78.
79.
Ordering Recommendation:   Aids in the detection of insulinoma. Do not use to diagnose diabetes mellitus.
80.
81.
Ordering Recommendation:   May be used as an adjunct to IGF-1 in diagnosis of growth disorders.
82.
83.
Ordering Recommendation:   Aids in management of individuals treated with interferon beta.
84.
85.
86.
Ordering Recommendation:   Primarily for research and to support attempts to understand the pathogenesis of immune, infectious, allergic, or inflammatory disorders.
87.
Ordering Recommendation:   Primarily for research and to support attempts to understand the pathogenesis of immune, infectious, allergic, or inflammatory disorders.
88.
Ordering Recommendation:   Primarily for research and to support attempts to understand the pathogenesis of immune, infectious, allergic, or inflammatory disorders.
89.
Ordering Recommendation:   Primarily for research and to support attempts to understand the pathogenesis of immune, infectious, allergic, or inflammatory disorders.
90.
Ordering Recommendation:   Primarily for research and to support attempts to understand the pathogenesis of immune, infectious, allergic, or inflammatory disorders.
91.
Ordering Recommendation:   Primarily for research and to support attempts to understand the pathogenesis of immune, infectious, allergic, or inflammatory disorders.
92.
Ordering Recommendation:   Primarily for research and to support attempts to understand the pathogenesis of immune, infectious, allergic, or inflammatory disorders.
93.
Ordering Recommendation:   Predict response to peginterferon (PEG-IFNa) and ribavirin (RBV) therapy for chronic HCV-1 infection.
94.
Ordering Recommendation:   Primarily for research and to support attempts to understand the pathogenesis of immune, infectious, allergic, or inflammatory disorders.
95.
Ordering Recommendation:   Primarily for research and to support attempts to understand the pathogenesis of immune, infectious, allergic, or inflammatory disorders.
96.
Ordering Recommendation:   Primarily for research and to support attempts to understand the pathogenesis of immune, infectious, allergic, or inflammatory disorders.
97.
Ordering Recommendation:   Primarily for research and to support attempts to understand the pathogenesis of immune, infectious, allergic, or inflammatory disorders.
98.
99.
Ordering Recommendation:   This test reports iodide, a subset of the total iodine present and is recommended for determination of toxic exposures to iodide containing compounds. This test is not recommended for the assessment of iodine status. Order Iodine Urine (2007465) for the assessment of iodine nutritional status.
100.
Ordering Recommendation:   Recommended for determination of iodine excess and monitoring iodine overload in patients administered iodine-containing medications. This test reports total iodine from all iodine-containing species present in the specimen but does not determine the chemical form (species) of the iodine present. For the assessment of nutritional status, Iodine, Urine (2007465) is preferred.
101.
Ordering Recommendation:   Recommended for the assessment of iodine nutritional status. This test reports total iodine from all iodine-containing species present in the specimen but does not determine the chemical form (species) of the iodine present. For determination of iodine excess and monitoring iodine overload in patients administered iodine-containing medications, refer to Iodine, Serum (2007463).
102.
103.
104.
Ordering Recommendation:   Aids in the diagnosis of iron deficiency, anemia, and iron overload.
105.
106.
Ordering Recommendation:   Useful in confirming hepatic iron overload, particularly in individuals with hemochromatosis and no common HFE mutations. Initial approach to diagnosis for hemochromatosis should include Iron and Iron Binding Capacity (0020420) (NOTE: test includes serum transferrin saturation) and Serum Ferritin (0070065).
107.
108.
Ordering Recommendation:   May be useful with other markers (GAD, IA-2A, IAA and/or ZnT8A) to establish a diagnosis of autoimmune type 1 diabetes mellitus (type 1A diabetes mellitus) in patients who have been biochemically diagnosed with diabetes mellitus.
109.
110.
111.
112.
Ordering Recommendation:   Monitor exposure to isopropanol.
113.
114.
Ordering Recommendation:   Optimize drug therapy and monitor patient adherence.